Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Central and peripheral nervous system immune mediated demyelinating disease after allogeneic hemopoietic stem cell transplantation for hematologic disease.
Primaquine treatment suppresses experimental autoimmune encephalomyelitis severity.
Determining the Presence of Reliable Change over Time in Multiple Sclerosis: Evidence from the PASAT, Adjusting-PSAT, and Stroop Test.
Teriflunomide for the treatment of multiple sclerosis.
Can a Low-Cost Webcam be Used for a Remote Neurological Exam?
Collateral Damage: Contribution of Peripheral Inflammation to Neurodegenerative Diseases.
Assessment of definitions of sustained disease progression in relapsing-remitting multiple sclerosis.
Astrocyte-derived VEGF-A drives blood-brain barrier disruption in CNS inflammatory disease.
Multiple neurological abnormalities, including pontine hemorrhage, multiple sclerosis and aseptic meningitis, during anti-TNF-α therapy in psoriatic arthritis.
Nature plus nurture: the triggering of multiple sclerosis.
Enzymatic deglycosylation converts pathogenic neuromyelitis optica anti-aquaporin-4 immunoglobulin G into therapeutic antibody.
The Neuro-Immune Pathophysiology of Central and Peripheral Fatigue in Systemic Immune-Inflammatory and Neuro-Immune Diseases.
Case of Type 1 Diabetes Mellitus Following Interferon β-1a Treatment for Multiple Sclerosis.
Vitamin D in Systemic and Organ-Specific Autoimmune Diseases.
Hughes syndrome and Multiple sclerosis.
Exercise in the community for people with minimal gait impairment due to MS: an assessor-blind randomized controlled trial.
Cytokines and matrix metalloproteinases in the cerebrospinal fluid of patients with acute transverse myelitis: an outcome analysis.
A Voxel-based Morphometry Study of Grey Matter Volume Changes in Neuromyelitis Optica Patients.
Fingolimod-associated amenorrhea: a report of three cases.
Commentary on "Possible induction of acute disseminated encephalomyelitis (ADEM)-like demyelinating illness by intrathecal mesenchymal stem cell injection"
Examining multiple sclerosis through the eyes of a child.
Multiple sclerosis and herpesvirus interaction.
Mirna-Mediated Macrophage Polarization and its Potential Role in the Regulation of Inflammatory Response.
Positive Effect on Multiple Sclerosis With Treatment of Metabolic Syndrome.
Opexa's Tovaxin® for the Treatment of Multiple Sclerosis Granted Fast Track Designation by FDA
Pages
« first
‹ previous
…
285
286
287
288
289
290
291
292
293
…
next ›
last »